Studies in normoprolactinemic individuals evaluating dyslipidemia, CVD, and CVD mortality populational studies evaluating PRL, CVD risk factors, and CVD mortality are summarized in tables (Table 3) (Table 4). Here, PRL is linked to metabolic syndrome.